---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-029280"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2026-06-18T18:59:46+00:00"
generated_at: "2026-06-18T19:01:07.422838+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Provectus Biopharmaceuticals annual meeting update; no specific financial data in filing

## Summary
- Filing states a presentation will be given at the 2026 annual meeting; no financial results or material events disclosed.
- Exhibit 99.1 (presentation slides) is referenced but not included in the provided text.
- No specific numbers, names, or events beyond the general update description.

## SEC filing metadata
- accession: 0001493152-26-029280
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2026-06-18T18:59:46+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000149315226029280/0001493152-26-029280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000149315226029280/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-029280
- JSON: https://secwatch.observer/filing/0001493152-26-029280.json
- Plain text: https://secwatch.observer/filing/0001493152-26-029280.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.